Core Viewpoint - Zhongtai Securities has received approval from the China Securities Regulatory Commission (CSRC) for a private placement of 6 billion yuan, marking a significant step in its capital-raising efforts after a prolonged period of inactivity in equity financing [1][8]. Summary by Sections Approval and Issuance - On October 13, Zhongtai Securities announced that it received the CSRC's approval for a stock issuance to specific investors, which must be executed according to the submitted documents and issuance plan [1]. - The approval is valid for 12 months from the date of registration [1]. Fundraising Details - The private placement will raise up to 6 billion yuan, with the number of shares issued not exceeding 30% of the company's total share capital prior to the issuance, equating to a maximum of 2.091 billion shares [3]. - The controlling shareholder, Zao Mining Group, is set to subscribe for 36.09% of the new shares, amounting to no more than 2.166 billion yuan [3]. Use of Proceeds - The funds raised will be allocated to six key areas, including: 1. Information technology and compliance risk control: up to 1.5 billion yuan 2. Alternative investment business: up to 1 billion yuan 3. Market-making business: up to 1 billion yuan 4. Purchase of government bonds and corporate bonds: up to 500 million yuan 5. Wealth management business: up to 500 million yuan 6. Debt repayment and operational capital: up to 1.5 billion yuan [4]. Historical Context - The plan for this private placement was initiated over two years ago, with the first proposal made on June 30, 2023, marking the company's first equity financing since its listing in 2020 [6]. - The proposal's validity was extended multiple times, with the latest extension allowing it to remain effective until July 14, 2026 [6][7]. Market Position and Strategy - Zhongtai Securities has not engaged in equity refinancing since its listing, relying instead on non-equity financing methods, which has led to a relatively high debt level and insufficient net capital replenishment [7]. - The company views this fundraising as a necessary step to align with regulatory support for capital replenishment and to enhance its service capabilities for the real economy [6][7].
又一券商“补血”!中泰证券60亿元定增获批